ANDEXXA Trademark

Trademark Overview

On Friday, October 2, 2015, a trademark application was filed for ANDEXXA with the United States Patent and Trademark Office. The USPTO has given the ANDEXXA trademark a serial number of 86776730. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, April 23, 2024. This trademark is owned by Portola Pharmaceuticals, Inc.. The ANDEXXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation
andexxa

General Information

Serial Number86776730
Word MarkANDEXXA
Filing DateFriday, October 2, 2015
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, April 23, 2024
Registration Number5251742
Registration DateTuesday, July 25, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in oncology and hematology; pharmaceutical preparations for the treatment of coagulation disorders, thrombosis, hematologic cancers, and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 7, 2015
Primary Code005
First Use Anywhere DateMonday, May 1, 2017
First Use In Commerce DateMonday, May 1, 2017

Trademark Owner History

Party NameALEXION PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBOSTON, MA 02210
Party NamePORTOLA PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSOUTH SAN FRANCISCO, MO 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePortola Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, October 6, 2015NEW APPLICATION ENTERED
Wednesday, October 7, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 22, 2016ASSIGNED TO EXAMINER
Saturday, January 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 17, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 4, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, October 4, 2016SOU EXTENSION 1 FILED
Tuesday, October 4, 2016SOU EXTENSION 1 GRANTED
Thursday, October 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 7, 2017SOU TEAS EXTENSION RECEIVED
Friday, April 7, 2017SOU EXTENSION 2 FILED
Friday, April 7, 2017SOU EXTENSION 2 GRANTED
Tuesday, April 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 2, 2017USE AMENDMENT FILED
Tuesday, May 2, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, May 25, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 26, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 21, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, June 22, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 25, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, February 12, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 12, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 13, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 25, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 16, 2024TEAS SECTION 8 RECEIVED
Wednesday, January 24, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, April 22, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 23, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, April 23, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, March 18, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 18, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 18, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 18, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

andexxa pharmaceutical preparations hematologic inflammation thrombosis cancers coagulation oncology hematology treatment